The subresolution DaTSCAN phantom: a cost-effective, flexible alternative to traditional phantom technology

The Alderson striatal phantom is frequently used to assess 123I-FP-CIT (Ioflupane) image quality and to test semi-quantification software. However, its design is associated with a number of limitations, in particular: unrealistic image appearances and inflexibility. A new physical phantom approach is proposed on the basis of subresolution phantom technology. The design incorporates thin slabs of attenuating material generated through additive manufacturing, and paper sheets with radioactive ink patterns printed on their surface, created with a conventional inkjet printer. The paper sheets and attenuating slabs are interleaved before scanning. Use of thin layers ensures that they cannot be individually resolved on reconstructed images. An investigation was carried out to demonstrate the performance of such a phantom in producing simplified 123I-FP-CIT uptake patterns. Single photon emission computed tomography imaging was carried out on an assembled phantom designed to mimic a healthy patient. Striatal binding ratio results and linear striatal dimensions were calculated from the reconstructed data and compared with that of 22 clinical patients without evidence of Parkinsonian syndrome, determined from clinical follow-up. Striatal binding ratio results for the fully assembled phantom were: 3.1, 3.3, 2.9 and 2.6 for the right caudate, left caudate, right putamen and right caudate, respectively. All were within two SDs of results derived from a cohort of clinical patients. Medial–lateral and anterior–posterior dimensions of the simulated striata were also within the range of values seen in clinical data. This work provides the foundation for the generation of a range of more clinically realistic, physical phantoms.

[1]  Rosemary J Morton,et al.  Variation of DaTSCAN quantification between different gamma camera types , 2005, Nuclear medicine communications.

[2]  K. Laere,et al.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[4]  J Mazziotta,et al.  A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[5]  Jacques Darcourt,et al.  Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  Kirsty C. Jordan,et al.  Technical Note: Development of a 3D printed subresolution sandwich phantom for validation of brain SPECT analysis. , 2016, Medical physics.

[7]  Pablo Aguiar,et al.  Validation of semi-quantitative methods for DAT SPECT: influence of anatomical variability and partial volume effect , 2015, Physics in medicine and biology.

[8]  Elena Salvatore,et al.  Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  Brian F. Hutton,et al.  The impact of reconstruction method on the quantification of DaTSCAN images , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  Ignace Lemahieu,et al.  Experimental Performance Assessment of SPM for SPECT Neuroactivation Studies Using a Subresolution Sandwich Phantom Design , 2002, NeuroImage.

[11]  Walter Koch,et al.  Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  Osama Sabri,et al.  Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  Peter Bartenstein,et al.  Radius dependence of FP-CIT quantification: a Monte Carlo-based simulation study , 2014, Annals of Nuclear Medicine.

[14]  John S. Fleming,et al.  Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  Robin B. Holmes,et al.  Generation of realistic HMPAO SPECT images using a subresolution sandwich phantom , 2013, NeuroImage.

[16]  E Spezi,et al.  A novel phantom technique for evaluating the performance of PET auto-segmentation methods in delineating heterogeneous and irregular lesions , 2015, EJNMMI Physics.

[17]  Claus Svarer,et al.  Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  Lars Johansson,et al.  A novel phantom design for emission tomography enabling scatter- and attenuation-”free” single-photon emission tomography imaging , 2000, European Journal of Nuclear Medicine.